Parkinson’s infusion therapy shows manageable psychiatric risks in real-world study
A real-world study of 77 advanced Parkinson's patients finds that neuropsychiatric side effects of foslevodopa/foscarbidopa infusion occur more often than ...
A real-world study of 77 advanced Parkinson's patients finds that neuropsychiatric side effects of foslevodopa/foscarbidopa infusion occur more often than ...
The first prospective real-world study of its kind found that most Parkinson's disease patients with uncontrolled motor fluctuations remained on ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine